(R) - MG132
Catalog #
27226
$130
*
●
●
Purchase
Description
(R)-MG132 is a potent, cell permeable and reversible inhibitor of proteasomes. It can inhibit proteasome activity in lysates of J558L multiple myeloma cells and EMT6 breast cancer cells. In comparison to (S)-MG132, the (R)-MG132 stereoisomer is a more effective inhibitor of chymotrypsin-like (ChTL), trypsin-like (TL), and peptidylglutamyl peptide hydrolyzing proteasome (PGPH) activities.
●
Synonyms
MG132
●
Product Data Gallery
Product Info
Storage and Usage
Citations
Purity
≥97% by HPLC
Format
A crystalline solid.
Formula
C26H41N3O5
MW
475.6 Da
Solubility
Soluble in ethanol, DMSO and DMF, purged with an inert gas. Solubility in these solvents is approximately 25 mg/ml. Do not store aqueous solutions for more than one day.
Biological Activity
(R)-MG132 inhibits ChTL, TL and PGPH with IC50 values of 0.22 µM, 34.4 µM, and 2.95 µM, respectively.
CAS Registry #
1211877-36-9
References
1. Lee, D.H., et al., Trends Cell Biol. 1998;8:397-403
2. Elliot, P.J., et al., J. Mol. Med. 2003;81:235-245
3. Mroczkiewicz, M., et al., J. Med. Chem. 2010;53:1509-1518.
2. Elliot, P.J., et al., J. Mol. Med. 2003;81:235-245
3. Mroczkiewicz, M., et al., J. Med. Chem. 2010;53:1509-1518.